Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital

NCT04177615 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 109

Last updated 2019-11-26

No results posted yet for this study

Summary

This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients

Conditions

  • Stroke, Acute
  • Basilar Artery Occlusion

Interventions

PROCEDURE

Thromboectomy

Thromboectomy in Basilar Artery Occlusion patients

Sponsors & Collaborators

  • University of Medicine and Pharmacy at Ho Chi Minh City

    lead OTHER

Principal Investigators

  • TUAN D Tran, MD · UMP university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-19
Primary Completion
2020-11-19
Completion
2020-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04177615 on ClinicalTrials.gov